BioCentury | Apr 18, 2016
Financial News

Kala Pharmaceuticals completes venture financing

...Advisors; Vivo Capital; Caxton Alternative Management; RA Capital Management; Wellington Management; Polaris Partners; Lux Capital; CVF...
BioCentury | Dec 24, 2012
Financial News

Cerulean financial update

...bringing the total raised in the round to $28 million. All existing investors participated, including CVF...
BioCentury | Oct 15, 2012
Financial News

Genocea completes venture financing

...Cambridge, Mass. Business: Infectious Date completed: 10/10/12 Type: Venture financing Raised: $30 million Investors: CVF...
BioCentury | Oct 11, 2012
Financial News

Genocea adds $30M in C round

...Inc. (Cambridge, Mass.) raised $30 million in a series C round led by new investor CVF...
BioCentury | Dec 19, 2011
Financial News

Cerulean completes venture financing

...Mass. Business: Drug delivery, Cancer Date completed: 12/15/11 Type: Venture financing Raised: $15 million Investors: CVF...
BioCentury | Apr 2, 2001
Tools & Techniques

VEGF: Scrapie: Making progress

...complement system, in the onset of prion disease, the U.K. researchers used cobra venom factor CVF...
...when injected into the blood. When the scientists injected the infectious scrapie agent intravenously into CVF-treated...
...the animals showed clinical signs of the disease after 298 (+/-11) days. Untreated controls and CVF-treated...
Items per page:
1 - 6 of 6
BioCentury | Apr 18, 2016
Financial News

Kala Pharmaceuticals completes venture financing

...Advisors; Vivo Capital; Caxton Alternative Management; RA Capital Management; Wellington Management; Polaris Partners; Lux Capital; CVF...
BioCentury | Dec 24, 2012
Financial News

Cerulean financial update

...bringing the total raised in the round to $28 million. All existing investors participated, including CVF...
BioCentury | Oct 15, 2012
Financial News

Genocea completes venture financing

...Cambridge, Mass. Business: Infectious Date completed: 10/10/12 Type: Venture financing Raised: $30 million Investors: CVF...
BioCentury | Oct 11, 2012
Financial News

Genocea adds $30M in C round

...Inc. (Cambridge, Mass.) raised $30 million in a series C round led by new investor CVF...
BioCentury | Dec 19, 2011
Financial News

Cerulean completes venture financing

...Mass. Business: Drug delivery, Cancer Date completed: 12/15/11 Type: Venture financing Raised: $15 million Investors: CVF...
BioCentury | Apr 2, 2001
Tools & Techniques

VEGF: Scrapie: Making progress

...complement system, in the onset of prion disease, the U.K. researchers used cobra venom factor CVF...
...when injected into the blood. When the scientists injected the infectious scrapie agent intravenously into CVF-treated...
...the animals showed clinical signs of the disease after 298 (+/-11) days. Untreated controls and CVF-treated...
Items per page:
1 - 6 of 6